US Stock MarketDetailed Quotes

Universe Pharmaceuticals (UPC)

Watchlist
  • 4.590
  • +0.401+9.58%
Close Jan 15 16:00 ET
2.59MMarket Cap-0.02P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Universe Pharmaceuticals (UPC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2024
(FY)Sep 30, 2023
(FY)Sep 30, 2022
(FY)Sep 30, 2021
(FY)Sep 30, 2020
(FY)Sep 30, 2019
(FY)Sep 30, 2018
Total revenue
-28.74%23.02M
-19.52%32.31M
-16.34%40.14M
56.27%47.98M
-7.60%30.7M
16.54%33.23M
28.51M
Operating revenue
-28.74%23.02M
-19.52%32.31M
-16.34%40.14M
56.27%47.98M
-7.60%30.7M
16.54%33.23M
--28.51M
Cost of revenue
-22.92%16.95M
20.50%21.99M
-19.44%18.25M
36.40%22.66M
-16.20%16.61M
31.22%19.82M
15.11M
Gross profit
-41.14%6.07M
-52.88%10.32M
-13.56%21.89M
79.70%25.33M
5.12%14.09M
-0.01%13.41M
13.41M
Operating expense
-1.33%14.09M
-50.60%14.28M
146.34%28.91M
205.46%11.74M
5.13%3.84M
-2.61%3.65M
3.75M
Selling and administrative expenses
16.04%10.44M
-56.80%9M
244.79%20.84M
116.21%6.04M
21.93%2.8M
-3.88%2.29M
--2.39M
-Selling and marketing expense
20.81%7.26M
-67.19%6.01M
515.58%18.3M
91.16%2.97M
-1.47%1.56M
-6.04%1.58M
--1.68M
-General and administrative expense
6.47%3.19M
18.32%3M
-17.53%2.53M
147.64%3.07M
73.69%1.24M
1.25%713.65K
--704.87K
Research and development costs
-37.61%3.03M
-36.44%4.86M
39.86%7.64M
837.31%5.47M
-5.71%583.13K
-21.66%618.44K
--789.38K
Depreciation amortization depletion
7.24%209.6K
5.55%195.45K
7.37%185.17K
-8.60%172.45K
-9.81%188.67K
-10.53%209.19K
--233.81K
-Depreciation and amortization
7.24%209.6K
5.55%195.45K
7.37%185.17K
-8.60%172.45K
-9.81%188.67K
-10.53%209.19K
--233.81K
Provision for doubtful accounts
--131.58K
--0
----
-334.63%-230.18K
-67.08%98.1K
188.05%297.97K
--103.45K
Other taxes
37.42%246.24K
-12.84%179.19K
-8.21%205.58K
44.25%223.98K
-9.02%155.27K
-6.38%170.66K
--182.29K
Other operating expenses
-38.83%28.84K
19.21%47.15K
-35.09%39.56K
179.22%60.94K
-66.89%21.83K
12.61%65.92K
--58.54K
Operating profit
-102.21%-8.02M
43.50%-3.97M
-151.65%-7.02M
32.56%13.59M
5.12%10.25M
1.00%9.75M
9.66M
Net non-operating interest income expense
-77.42%-278.17K
3.46%-156.79K
-59.84%-162.4K
17.90%-101.6K
4.26%-123.76K
21.62%-129.27K
-164.92K
Non-operating interest expense
77.42%278.17K
-3.46%156.79K
59.84%162.4K
-17.90%101.6K
-4.26%123.76K
-21.62%129.27K
--164.92K
Other net income (expense)
186.74%177.42K
-333.69%-204.54K
-53.92%87.53K
789.90%189.94K
-193.33%-27.53K
10.72%29.5K
26.64K
Gain on sale of security
----
108.19%38.53K
-296.40%-470.48K
--239.55K
----
----
----
Earnings from equity interest
2.80%31.94K
-19.48%31.07K
25.18%38.59K
41.28%30.83K
-18.40%21.82K
23.63%26.74K
--21.63K
Special income (charges)
----
204.76%439.33K
-282.19%-419.35K
334.63%230.18K
67.08%-98.1K
-188.05%-297.97K
---103.45K
-Write off
----
-204.76%-439.33K
282.19%419.35K
-334.63%-230.18K
-67.08%98.1K
188.05%297.97K
--103.45K
Other non- operating income (expenses)
161.74%145.48K
-581.43%-235.61K
160.84%48.94K
-62.98%-80.43K
-1,888.12%-49.35K
-44.95%2.76K
--5.01K
Income before tax
-87.65%-8.12M
39.00%-4.33M
-151.86%-7.09M
35.42%13.68M
4.63%10.1M
1.42%9.65M
9.52M
Income tax
-73.08%606.7K
176.41%2.25M
-65.43%815.32K
-7.23%2.36M
20.97%2.54M
9.74%2.1M
1.92M
Net income
-32.61%-8.73M
16.80%-6.58M
-169.87%-7.91M
49.77%11.32M
0.09%7.56M
-0.68%7.55M
7.6M
Net income continuous Operations
-32.61%-8.73M
16.80%-6.58M
-169.87%-7.91M
49.77%11.32M
0.09%7.56M
-0.68%7.55M
--7.6M
Minority interest income
Net income attributable to the parent company
-32.61%-8.73M
16.80%-6.58M
-169.87%-7.91M
49.77%11.32M
0.09%7.56M
-0.68%7.55M
7.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-32.61%-8.73M
16.80%-6.58M
-169.87%-7.91M
49.77%11.32M
0.09%7.56M
-0.68%7.55M
7.6M
Basic earnings per share
42.44%-639.4992
16.80%-1.11K
-162.16%-1.34K
65.77%2.15K
0.09%1.3K
-0.68%1.29K
1.3K
Diluted earnings per share
42.44%-639.4992
16.80%-1.11K
-162.16%-1.34K
65.77%2.15K
0.09%1.3K
-0.68%1.29K
1.3K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
--
--
(FY)Sep 30, 2024(FY)Sep 30, 2023(FY)Sep 30, 2022(FY)Sep 30, 2021(FY)Sep 30, 2020(FY)Sep 30, 2019(FY)Sep 30, 2018
Total revenue -28.74%23.02M-19.52%32.31M-16.34%40.14M56.27%47.98M-7.60%30.7M16.54%33.23M28.51M
Operating revenue -28.74%23.02M-19.52%32.31M-16.34%40.14M56.27%47.98M-7.60%30.7M16.54%33.23M--28.51M
Cost of revenue -22.92%16.95M20.50%21.99M-19.44%18.25M36.40%22.66M-16.20%16.61M31.22%19.82M15.11M
Gross profit -41.14%6.07M-52.88%10.32M-13.56%21.89M79.70%25.33M5.12%14.09M-0.01%13.41M13.41M
Operating expense -1.33%14.09M-50.60%14.28M146.34%28.91M205.46%11.74M5.13%3.84M-2.61%3.65M3.75M
Selling and administrative expenses 16.04%10.44M-56.80%9M244.79%20.84M116.21%6.04M21.93%2.8M-3.88%2.29M--2.39M
-Selling and marketing expense 20.81%7.26M-67.19%6.01M515.58%18.3M91.16%2.97M-1.47%1.56M-6.04%1.58M--1.68M
-General and administrative expense 6.47%3.19M18.32%3M-17.53%2.53M147.64%3.07M73.69%1.24M1.25%713.65K--704.87K
Research and development costs -37.61%3.03M-36.44%4.86M39.86%7.64M837.31%5.47M-5.71%583.13K-21.66%618.44K--789.38K
Depreciation amortization depletion 7.24%209.6K5.55%195.45K7.37%185.17K-8.60%172.45K-9.81%188.67K-10.53%209.19K--233.81K
-Depreciation and amortization 7.24%209.6K5.55%195.45K7.37%185.17K-8.60%172.45K-9.81%188.67K-10.53%209.19K--233.81K
Provision for doubtful accounts --131.58K--0-----334.63%-230.18K-67.08%98.1K188.05%297.97K--103.45K
Other taxes 37.42%246.24K-12.84%179.19K-8.21%205.58K44.25%223.98K-9.02%155.27K-6.38%170.66K--182.29K
Other operating expenses -38.83%28.84K19.21%47.15K-35.09%39.56K179.22%60.94K-66.89%21.83K12.61%65.92K--58.54K
Operating profit -102.21%-8.02M43.50%-3.97M-151.65%-7.02M32.56%13.59M5.12%10.25M1.00%9.75M9.66M
Net non-operating interest income expense -77.42%-278.17K3.46%-156.79K-59.84%-162.4K17.90%-101.6K4.26%-123.76K21.62%-129.27K-164.92K
Non-operating interest expense 77.42%278.17K-3.46%156.79K59.84%162.4K-17.90%101.6K-4.26%123.76K-21.62%129.27K--164.92K
Other net income (expense) 186.74%177.42K-333.69%-204.54K-53.92%87.53K789.90%189.94K-193.33%-27.53K10.72%29.5K26.64K
Gain on sale of security ----108.19%38.53K-296.40%-470.48K--239.55K------------
Earnings from equity interest 2.80%31.94K-19.48%31.07K25.18%38.59K41.28%30.83K-18.40%21.82K23.63%26.74K--21.63K
Special income (charges) ----204.76%439.33K-282.19%-419.35K334.63%230.18K67.08%-98.1K-188.05%-297.97K---103.45K
-Write off -----204.76%-439.33K282.19%419.35K-334.63%-230.18K-67.08%98.1K188.05%297.97K--103.45K
Other non- operating income (expenses) 161.74%145.48K-581.43%-235.61K160.84%48.94K-62.98%-80.43K-1,888.12%-49.35K-44.95%2.76K--5.01K
Income before tax -87.65%-8.12M39.00%-4.33M-151.86%-7.09M35.42%13.68M4.63%10.1M1.42%9.65M9.52M
Income tax -73.08%606.7K176.41%2.25M-65.43%815.32K-7.23%2.36M20.97%2.54M9.74%2.1M1.92M
Net income -32.61%-8.73M16.80%-6.58M-169.87%-7.91M49.77%11.32M0.09%7.56M-0.68%7.55M7.6M
Net income continuous Operations -32.61%-8.73M16.80%-6.58M-169.87%-7.91M49.77%11.32M0.09%7.56M-0.68%7.55M--7.6M
Minority interest income
Net income attributable to the parent company -32.61%-8.73M16.80%-6.58M-169.87%-7.91M49.77%11.32M0.09%7.56M-0.68%7.55M7.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -32.61%-8.73M16.80%-6.58M-169.87%-7.91M49.77%11.32M0.09%7.56M-0.68%7.55M7.6M
Basic earnings per share 42.44%-639.499216.80%-1.11K-162.16%-1.34K65.77%2.15K0.09%1.3K-0.68%1.29K1.3K
Diluted earnings per share 42.44%-639.499216.80%-1.11K-162.16%-1.34K65.77%2.15K0.09%1.3K-0.68%1.29K1.3K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion----
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -